Clinical Trials in New York

Showing 21-40 of 17,259 trials

Efficacy and Utility of Cxbladder Tests in Hematuria Patients

NCT04943380

Prospective observational study to validate the performance characteristics and clinical utility of Cxbladder tests in a Veterans Affairs cohort.

HematuriaUrothelial Carcinoma

Pacific Edge Limited682 participantsStarted Nov 2019

San Diego, California, United States • Bay Pines, Florida, United States • Miami, Florida, United States +7 more locations

Not Yet RecruitingPhase 2< 1 mile

Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation

NCT07549503

This is a prospective multi-center, longitudinal study to determine efficacy of 50 percent Immunosuppression (IS) reduction. One hundred fully eligible participants will reduce IS by 50 percent in two steps. Liver tests will be checked every 0.5 months through month 4, once a month through month 12, and every other month through month 18. Liver transplant (LTx) center visits will take place at screening, months 6, 12 and 18 after initiating IS dose reduction. A protocol driven liver biopsy to adjudicate the endpoint will be performed at 18 months. The duration of the study from time of starting IS dose reduction to the primary endpoint assessment is 18 months. The primary objective is to assess the efficacy of 50 percent IS dose reduction in children with Liver transplants (LTxs)

Liver Transplant

National Institute of Allergy and Infectious Diseases (NIAID)100 participantsStarted May 2026

San Francisco, California, United States • Aurora, Colorado, United States • Washington D.C., District of Columbia, United States +7 more locations

Efficacy and Utility of Cxbladder Tests in Hematuria Patients

Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation

Find Trials by Condition in New York

Psilocybin for Major Depressive Disorder (MDD)

Obstructive Sleep Apnea (OSA) and Sex-Specific Responses to N-acetylcysteine (NAC)

Safety and Efficacy Study of VIS649 for IgA Nephropathy

Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer

Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate

Detection and Risk Stratification in Veterans Presenting With Microscopic Hematuria

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight

Cigarette Filter Study

The Effect of Celecoxib on Neuroinflammation in MDD

First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations

Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity

A Study of TYRA-300 in Children With Achondroplasia: BEACH301

A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)

Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta